The CEO of Germany's Merck ... an all-stock deal, according to a statement seen by Reuters. Biotech firm Recursion to buy smaller peer Exscientia for $688 million August 8, 2024 Merck KGaA is ...
Merck & Co. (MRK) stock lost over 9% yesterday on announcing a temporary shipment halt of its Gardasil vaccine to China. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback